BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24114680)

  • 1. Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater: a population-based study.
    Randle RW; Ahmed S; Newman NA; Clark CJ
    J Gastrointest Surg; 2014 Feb; 18(2):354-62. PubMed ID: 24114680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
    Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
    J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.
    Onkendi EO; Boostrom SY; Sarr MG; Farnell MB; Nagorney DM; Donohue JH; Kendrick ML; Reid-Lombardo KM; Harmsen WS; Que FG
    J Gastrointest Surg; 2012 Apr; 16(4):682-91. PubMed ID: 22350721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
    Untch BR; Bonner KP; Roggin KK; Reidy-Lagunes D; Klimstra DS; Schattner MA; Fong Y; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Kingham TP; Tang LH
    J Gastrointest Surg; 2014 Mar; 18(3):457-62; discussion 462-3. PubMed ID: 24448999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duodenal and Ampullary Carcinoid Tumors: Size Predicts Necessity for Lymphadenectomy.
    Dogeas E; Cameron JL; Wolfgang CL; Hirose K; Hruban RH; Makary MA; Pawlik TA; Choti MA
    J Gastrointest Surg; 2017 Aug; 21(8):1262-1269. PubMed ID: 28516311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct.
    Michelassi F; Erroi F; Dawson PJ; Pietrabissa A; Noda S; Handcock M; Block GE
    Ann Surg; 1989 Oct; 210(4):544-54; discussion 554-6. PubMed ID: 2679459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ampullary Neuroendocrine Tumors: Insight into a Rare Histology.
    Ruff SM; Standring O; Wu G; Levy A; Anantha S; Newman E; Karpeh MS; Nealon W; Deutsch GB; Weiss MJ; DePeralta DK
    Ann Surg Oncol; 2021 Dec; 28(13):8318-8328. PubMed ID: 34312800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
    Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic T1 subclassification of ampullary carcinoma with perisphincteric or duodenal submucosal invasion: Is it T1b?
    You D; Heo J; Choi S; Choi D; Jang KT
    Arch Pathol Lab Med; 2014 Aug; 138(8):1072-6. PubMed ID: 25076296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
    Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
    Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroendocrine Tumors (NETs) of the Minor Papilla/Ampulla: Analysis of 16 Cases Underlines Homology With Major Ampulla NETs and Differences From Extra-Ampullary Duodenal NETs.
    Vanoli A; Albarello L; Uncini S; Fassan M; Grillo F; Di Sabatino A; Martino M; Pasquali C; Milanetto AC; Falconi M; Partelli S; Doglioni C; Schiavo-Lena M; Brambilla T; Pietrabissa A; Sessa F; Capella C; Rindi G; La Rosa S; Solcia E; Paulli M
    Am J Surg Pathol; 2019 Jun; 43(6):725-736. PubMed ID: 30913089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
    Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
    J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of duodenal adenocarcinoma: ampullary vs. non-ampullary, short- and long-term outcomes.
    Tesarikova J; Skalicky P; Kurfurstova D; Svebisova H; Urban O; Falt P; Zapletalova J; Klos D; Lovecek M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Sep; 166(3):290-296. PubMed ID: 34012147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoids and high-grade neuroendocrine carcinomas of the ampulla of vater: a comparative analysis of 139 cases from the surveillance, epidemiology, and end results program-a population based study.
    Albores-Saavedra J; Hart A; Chablé-Montero F; Henson DE
    Arch Pathol Lab Med; 2010 Nov; 134(11):1692-6. PubMed ID: 21043824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
    Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
    World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.
    Shaib WL; Sharma R; Brutcher E; Kim S; Maithel SK; Chen Z; Kooby DA; Kauh J; Landry J; El-Rayes BF
    J Surg Oncol; 2014 May; 109(6):556-60. PubMed ID: 24338561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periampullary adenocarcinoma: analysis of 5-year survivors.
    Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
    Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical Strategy for T1 Duodenal or Ampullary Carcinoma According to the Depth of Tumor Invasion.
    Kohga A; Yamamoto Y; Sano S; Sugiura T; Okamura Y; Ito T; Ashida R; Ishiwatari H; Matsubayashi H; Sasaki K; Uesaka K
    Anticancer Res; 2017 Sep; 37(9):5277-5283. PubMed ID: 28870965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.